Comparing two procedures for treating stress urinary incontinence during vaginal prolapse repair
Official title: BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair
Run by University Hospitals Cleveland Medical Center · NCT06754046 · Data updated 2026-11-12
This study is testing whether a new type of surgery or an injection is better for helping women with stress urinary incontinence during vaginal prolapse repair.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 476 (estimated) |
| Sponsor | University Hospitals Cleveland Medical Center Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | May 1, 2025 |
| Main results expected | April 2029 |
| Study ends | April 2029 |
| Registry record updated | June 1, 2026 |
| Trial ID | NCT06754046 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18 and older with a diagnosis of symptomatic stress urinary incontinence who are planning to undergo vaginal prolapse repair.
✕Probably not a fit
Patients who are undergoing pelvic organ prolapse repair using mesh or biologic augmentation, or those with certain medical conditions that may complicate the procedure, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to determine whether retropubic midurethral sling (RP-MUS) or bulkamide injection (PAHG) is more effective for treating stress urinary incontinence (SUI) in women undergoing vaginal prolapse repair. Participants will be randomly assigned to one of the two procedures and will complete validated questionnaires at multiple time points over a 24-month period to assess their symptoms and quality of life. The study will also evaluate the complication rates and long-term outcomes associated with each procedure. Blinding will be maintained to ensure unbiased results, and qualitative interviews will be conducted with select participants to gather in-depth insights.
Why it matters
Potential benefit: If successful, this study could provide patients with a clearer understanding of the most effective treatment option for stress urinary incontinence during vaginal prolapse repair.
How similar studies have gone: Other studies have explored similar interventions for stress urinary incontinence, but this specific comparison of RP-MUS and PAHG is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women ≥ 18 years of age. * Have diagnosis of symptomatic or occult stress urinary incontinence (SUI) as noted in their electronic health record (EHR). * Proof of positive testing for SUI via cough stress test (CST) and/or Urodynamic (UDS) testing, * Patients that are planning and eligible for native tissue prolapse repair and for both Retropubic Midurethral Sling (RP-MUS) and Polyacrylamide Hydrogel (PAHG) Exclusion Criteria: * Patients undergoing pelvic organ prolapse repair using mesh or biologic augmentation other than patient's own tissue * Patient anticipating difficulty with completing 24-month follow-up * Anticipation of pregnancy within subsequent 24-months or \<18 months post-partum * Hemoglobin A1c \>10.0% within the past 3-months * Current smoker \> 1 pack per week * History of neurogenic bladder * Current use of any catheterization including but not limited to, intermittent catheterization, indwelling Foley catheter, or suprapubic catheter * Post-void residual \>150 mL felt to not be due to obstruction for prolapse * Prior history of any anti-incontinence procedure including but not limited to any synthetic sling, fascial sling, Burch colposuspension or its variants, and urethral bulking * Previous history of any pelvic radiation * Patient receiving a planned concurrent procedure at the time of prolapse repair.
Where it's running
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States Recruiting
Study contacts
- Principal investigator: David Sheyn, MD — University Hospitals Cleveland Medical Center
- Study coordinator: Elisar Khawam
- Email: Elisar.Khawam@UHhospitals.org
- Phone: 216-844-2493
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if increasing running cadence helps stress urinary incontinence in parous runners
This study tests whether increasing running cadence by about 10% for eight weeks can reduce stress urinary incontinence symptoms in parous women who run regularly and own a Garmin watch.
-
Prophylactic antibiotics to reduce post-procedure UTIs after urethral bulking
We’re testing whether giving a preventive antibiotic at the time of urethral bulking can lower the chance of a urinary tract infection after the procedure for women with stress or mixed urinary incontinence.
-
Evaluating the impact of different mesh widths in surgery for urinary incontinence
This study is testing whether using a wider surgical mesh during surgery for urinary incontinence in women can lead to better results and fewer problems.
-
Evaluating postoperative activity restrictions after midurethral sling placement
This study is testing whether patients who have had a midurethral sling procedure for stress urinary incontinence do better with strict activity limits or no limits after surgery.
-
Effectiveness and safety of shorter tapes for urinary incontinence
This study looks at whether shorter surgical tapes for treating urinary incontinence in women can improve their quality of life and have fewer complications compared to longer tapes.
-
Giving a single oral antibiotic dose with Bulkamid urethral bulking.
This will see if one dose of oral antibiotics given before Bulkamid urethral bulking lowers early urinary tract infections in people treated for stress‑predominant urinary incontinence.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.